Humana Inc. (NYSE:HUM) Shares Sold by Retirement Systems of Alabama

Retirement Systems of Alabama lowered its holdings in Humana Inc. (NYSE:HUM - Free Report) by 1.1% in the first quarter, according to its most recent disclosure with the SEC. The institutional investor owned 216,678 shares of the insurance provider's stock after selling 2,324 shares during the period. Retirement Systems of Alabama owned approximately 0.18% of Humana worth $57,333,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently made changes to their positions in the business. Dodge & Cox lifted its stake in Humana by 106.7% in the fourth quarter. Dodge & Cox now owns 10,198,040 shares of the insurance provider's stock worth $2,587,345,000 after acquiring an additional 5,264,045 shares during the last quarter. Vanguard Group Inc. lifted its stake in Humana by 15.8% in the fourth quarter. Vanguard Group Inc. now owns 12,829,210 shares of the insurance provider's stock worth $3,254,899,000 after acquiring an additional 1,751,857 shares during the last quarter. Norges Bank purchased a new position in Humana in the fourth quarter worth approximately $416,202,000. Pzena Investment Management LLC lifted its stake in Humana by 44.0% in the fourth quarter. Pzena Investment Management LLC now owns 3,609,382 shares of the insurance provider's stock worth $915,736,000 after acquiring an additional 1,103,132 shares during the last quarter. Finally, Boston Partners lifted its stake in Humana by 435.8% in the fourth quarter. Boston Partners now owns 1,098,702 shares of the insurance provider's stock worth $279,236,000 after acquiring an additional 893,637 shares during the last quarter. Institutional investors and hedge funds own 92.38% of the company's stock.

Humana Stock Performance

Shares of Humana stock opened at $243.60 on Friday. The company has a debt-to-equity ratio of 0.71, a current ratio of 1.91 and a quick ratio of 1.91. The stock has a market capitalization of $29.40 billion, a price-to-earnings ratio of 17.23, a PEG ratio of 1.84 and a beta of 0.43. The firm's fifty day simple moving average is $246.87 and its 200-day simple moving average is $261.37. Humana Inc. has a 12 month low of $212.45 and a 12 month high of $406.46.

Humana (NYSE:HUM - Get Free Report) last announced its quarterly earnings data on Wednesday, April 30th. The insurance provider reported $11.58 earnings per share (EPS) for the quarter, beating the consensus estimate of $10.07 by $1.51. The company had revenue of $32.11 billion for the quarter, compared to analysts' expectations of $32 billion. Humana had a net margin of 1.42% and a return on equity of 14.47%. Humana's revenue was up 8.4% compared to the same quarter last year. During the same period in the previous year, the company posted $7.23 EPS. As a group, equities analysts forecast that Humana Inc. will post 16.47 earnings per share for the current year.

Humana Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, July 25th. Shareholders of record on Friday, June 27th will be paid a $0.885 dividend. The ex-dividend date is Friday, June 27th. This represents a $3.54 annualized dividend and a yield of 1.45%. Humana's dividend payout ratio is currently 25.04%.

Wall Street Analysts Forecast Growth

HUM has been the subject of a number of recent research reports. Mizuho lifted their price target on shares of Humana from $305.00 to $316.00 and gave the stock an "outperform" rating in a research note on Wednesday, April 9th. Guggenheim initiated coverage on shares of Humana in a research note on Wednesday, April 9th. They issued a "buy" rating and a $326.00 price target for the company. Raymond James Financial upgraded shares of Humana from a "market perform" rating to an "outperform" rating and set a $315.00 price target for the company in a research note on Thursday, May 1st. Robert W. Baird lifted their price target on shares of Humana from $270.00 to $300.00 and gave the stock a "neutral" rating in a research note on Tuesday, April 15th. Finally, Oppenheimer lifted their price target on shares of Humana from $300.00 to $310.00 and gave the stock an "outperform" rating in a research note on Thursday, May 1st. Seventeen investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company's stock. According to data from MarketBeat, the stock has a consensus rating of "Hold" and an average target price of $280.76.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.